# Progress Note 01 — Initial plan

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Martin Luther (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-RE004-SYN
- Date: 2026-07-28
- Fictional facility: St. Posthumous Health Center
- Fictional author: Ottilie Brandt-Mensah, MD
- Calendar frame: modern shifted

## Subjective

The patient participates in this fictional visit for new patient visit for attacks of vertigo with left-ear tinnitus and muffled hearing, and low mood: history, neurological and ear examination, blood and urine tests, depression and safety screening, and an otology referral. **S**

## Objective

Hemoglobin: 15.1 g/dL; White cell count: 6.8 10*3/uL; Platelets: 238 10*3/uL; Sodium: 140 mmol/L; Potassium: 4.2 mmol/L; Bicarbonate: 26 mmol/L; Urea nitrogen: 15 mg/dL; Creatinine: 1.02 mg/dL; Glucose: 94 mg/dL; Calcium: 9.7 mg/dL; Uric acid: 6.9 mg/dL; TSH: 1.8 mIU/L; Urine red cells: 1 /[HPF]; Urine pH: 5.5 [pH]; eGFR: 94 mL/min/1.73 m²; PHQ-9: 15; GAD-7: 9. All results are synthetic.

BP 128/82 mmHg; pulse 76 bpm; respirations 14/min; temperature 36.7 °C; oxygen saturation 98% on room air; weight 86 kg; BMI 28.1 kg/m². All vital signs are synthetic.

## Assessment

Active problems: Recurrent attacks of spinning vertigo for about three months, the worst twelve days ago, lasting hours, with roaring tinnitus, fullness and muffled hearing in the left ear and nausea, the tinnitus persisting between attacks; with low mood, poor sleep and loss of interest; cause not established at intake: an inner-ear disorder suspected, with vestibular migraine, vestibular schwannoma and posterior circulation stroke to be excluded and depression to be assessed; otology consultation requested; Urinary stone disease: one stone passed spontaneously last year after severe pain; stone type and metabolic risk not yet known at intake. Strengths and supports remain part of the care plan. **S**

## Medication changes

- Started: Meclizine 25 mg tablet, one by mouth up to every 8 hours during a severe vertigo attack only, for no more than 3 days at a time **S**

## Plan

- Otology (neurotology) consultation in two weeks, with audiometry, to confirm the cause of the attacks and plan treatment. Guideline: Clinical Practice Guideline: Ménière's Disease (2020) **S**
- Diagnostic work-up at intake: ear and neurological examination, positional testing, blood count, kidney function and electrolytes, calcium, uric acid, TSH and urinalysis; a symptom diary of each attack (start, duration, hearing, tinnitus, ear fullness, headache, light sensitivity); formal audiometry at the otology visit. Guideline: Clinical Practice Guideline: Ménière's Disease (2020); Diagnostic criteria for Menière's disease (2015); Vestibular migraine: diagnostic criteria (update) (2022) **S**
- Meclizine only for severe attacks, for no more than three days at a time; sit or lie down at the first warning; no driving, ladders or swimming alone while attacks are active. Guideline: Clinical Practice Guideline: Ménière's Disease (2020) **S**
- Depression: PHQ-9 at every visit, a structured diagnostic interview at the next visit, and a safety plan with the 988 Suicide & Crisis Lifeline and the clinic number. Guideline: Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts (2019); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024) **S**
- Stone history: drink enough water to pass at least 2.5 liters of urine a day; serum calcium and uric acid at intake; stone analysis and metabolic testing if another stone occurs. Guideline: Medical Management of Kidney Stones: AUA Guideline (2014) **S**
